Ray-Ban maker's shares jump as strong eyewear sales temper AI glasses worries

By Reuters News

By Gianluca Lo Nostro

- Shares in EssilorLuxottica ESLX.PA rose more than 11% on Wednesday after the Ray-Ban maker beat third-quarter revenue expectations, with resilient demand for its core eyewear products outweighing signs of moderating growth in smart glasses.

The move is a sign of easing pressure on the world's largest eyewear company, whose stock has nearly halved in value after reaching a record market valuation of €149 billion ($167 billion) a year ago.

Analysts say the slump began as investors raised concerns over governance and the company's nascent smart glasses business, particularly around privacy and sales expectations.

EssilorLuxottica's shares were up 11.4% by 0712 GMT, leading gains on France's CAC 40 .FCHI benchmark index and trading at their highest price since August.

"The prospect of smart glasses disrupting traditional eyewear will likely stay as a sword of Damocles hanging over EssilorLuxottica," Bernstein analysts said in a note to investors.

With Alphabet's GOOGL.O Google set to launch its Gemini AI glasses by the end of 2026, it "makes sense for EssilorLuxottica to espouse a conservative message" on the fourth quarter's expectations, they added.

Third-quarter revenue at the Franco-Italian company was €7.49 billion, beating the €7.36 billion expected by analysts.

But unlike previous quarters, sales of the smart glasses made with Meta META.O slowed down compared with higher rates earlier in the year, while the group's eyewear core business was the main growth driver.

https://www.reuters.com/graphics/ESSILORLUXOTTICA-RESULTS/jnvwokdwdvw/chart.png

($1 = 0.8911 euros)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk